Cited 40 times in
Osteonecrosis of the jaw related to everolimus: a case report
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박형식 | - |
dc.contributor.author | 정영수 | - |
dc.contributor.author | 정휘동 | - |
dc.contributor.author | 김동욱 | - |
dc.date.accessioned | 2014-12-18T09:40:50Z | - |
dc.date.available | 2014-12-18T09:40:50Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 0266-4356 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/88625 | - |
dc.description.abstract | Antiresorptive agent-related osteonecrosis of the jaw results in appreciable morbidity in affected patients. Nowadays many physicians prescribe an antiangiogenic agent for the management of malignant metastases. Everolimus is a serine-threonine kinase that acts as an inhibitor of mammalian target of rapamycin, which results in reduced growth of cells, angiogenesis, and survival of cells. We report the first case to our knowledge of osteonecrosis of the jaw that seemed to result from the additive effect of everolimus. | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Angiogenesis Inhibitors/adverse effects* | - |
dc.subject.MESH | Bone Density Conservation Agents/therapeutic use | - |
dc.subject.MESH | Bone Neoplasms/drug therapy | - |
dc.subject.MESH | Bone Neoplasms/secondary | - |
dc.subject.MESH | Diphosphonates/therapeutic use | - |
dc.subject.MESH | Everolimus | - |
dc.subject.MESH | Follow-Up Studies | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Imidazoles/therapeutic use | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Mandibular Diseases/chemically induced* | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Osteonecrosis/chemically induced* | - |
dc.subject.MESH | Sirolimus/adverse effects | - |
dc.subject.MESH | Sirolimus/analogs & derivatives* | - |
dc.subject.MESH | Thyroid Neoplasms/surgery | - |
dc.subject.MESH | Thyroidectomy/methods | - |
dc.title | Osteonecrosis of the jaw related to everolimus: a case report | - |
dc.type | Article | - |
dc.contributor.college | College of Dentistry (치과대학) | - |
dc.contributor.department | Dept. of Oral and Maxillofacial Surgery (구강악안면외과학) | - |
dc.contributor.googleauthor | Dong Wook Kim | - |
dc.contributor.googleauthor | Young-Soo Jung | - |
dc.contributor.googleauthor | Hyung-Sik Park | - |
dc.contributor.googleauthor | Hwi-Dong Jung | - |
dc.identifier.doi | 10.1016/j.bjoms.2013.09.008 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A01755 | - |
dc.contributor.localId | A03655 | - |
dc.contributor.localId | A03792 | - |
dc.relation.journalcode | J00413 | - |
dc.identifier.eissn | 1532-1940 | - |
dc.identifier.pmid | 24094895 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S0266435613004269 | - |
dc.subject.keyword | ARONJ | - |
dc.subject.keyword | Anti-angiogenic agent | - |
dc.subject.keyword | Anti-resorptive agent related osteonecrosis of the jaw | - |
dc.subject.keyword | Everolimus | - |
dc.contributor.alternativeName | Park, Hyung Sik | - |
dc.contributor.alternativeName | Jung, Young Soo | - |
dc.contributor.alternativeName | Jung, Hwi Dong | - |
dc.contributor.affiliatedAuthor | Park, Hyung Sik | - |
dc.contributor.affiliatedAuthor | Jung, Young Soo | - |
dc.contributor.affiliatedAuthor | Jung, Hwi Dong | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 51 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 302 | - |
dc.citation.endPage | 304 | - |
dc.identifier.bibliographicCitation | BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, Vol.51(8) : 302-304, 2013 | - |
dc.identifier.rimsid | 33364 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.